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Background
Prominent features of myocardial remodeling in heart
failure with preserved ejection fraction (HFPEF) are high
cardiomyocyte resting tension (Fpassive) [1-4] and cardio-
myocyte hypertrophy [2]. In experimental models, both
reacted favorably to raised protein kinase G (PKG) activ-
ity [4,5]. The present study assessed myocardial PKG
activity, its downstream effects on cardiomyocyte Fpassive
and cardiomyocyte diameter, and its upstream control by
cyclic guanosine monophosphate (cGMP), nitrosative/
oxidative stress, and brain natriuretic peptide (BNP). To
discern altered control of myocardial remodeling by
PKG, HFPEF was compared with aortic stenosis and HF
with reduced EF (HFREF).
Results
Patients with HFPEF (n=36), AS (n=67), and HFREF
(n=43) were free of coronary artery disease. More HFPEF
patients were obese (P<0.05) or had diabetes mellitus
(P<0.05). Left ventricular myocardial biopsies were
procured transvascularly in HFPEF and HFREF and perio-
peratively in aortic stenosis. Fpassive was measured in cardi-
omyocytes before and after PKG administration.
Myocardial homogenates were used for assessment of PKG
activity, cGMP concentration, proBNP-108 expression, and
nitrotyrosine expression, a measure of nitrosative/oxidative
stress. Additional quantitative immunohistochemical analy-
sis was performed for PKG activity and nitrotyrosine
expression. Cardiomyocyte Fpassive was higher in HFPEF
(7.6±0.4 kN/m2) than in AS (3.4±0.2 kN/m2; P<0.001) and
in HFREF (5.1±0.2 kN/m2; P<0.001). In-vitro administra-
tion of PKG acutely lowered cardiomyocyte stiffness in all
groups with the largest decrement in Fpassive in DHF
patients. PKG activity in myocardial tissue homogenates
was significantly lower in HFPEF (5.11±0.62 pmol/min/
mg) than in both AS (9.18±0.64 pmol/min/mg; P<0.01)
and HFREF (11.51±2.0 pmol/min/mg; P<0.001). Immuno-
histochemical determination of myocardial PKG activity by
pVASP/VASP ratio provided confirmatory evidence as it
was also significantly lower in HFPEF (0.70±0.03) than in
both AS (0.84±0.02; P<0.001) and HFREF (0.85±0.03;
P<0.001). Lower PKG activity in HFPEF than in aortic ste-
nosis or HFREF was associated with higher cardiomyocyte
Fpassive (P<0.001) and related to lower cGMP concentration
(P<0.001) and higher nitrosative/ oxidative stress (P<0.05).
Reduced PKG activity and lower myocardial cGMP con-
centration in HFPEF did not result from altered myocardial
sGC or PDE5A expression, which was similar in all groups
nor from unequal BNP expression, which was comparable
in HFPEF and AS. The downregulated cGMP-PKG signal-
ing in HFPEF was therefore related to low myocardial
nitric oxide bioavailability because of high nitrosative/
oxidative stress.
Conclusion
Low myocardial PKG activity in HFPEF was associated
with raised cardiomyocyte Fpassive and was related to
increased myocardial nitrosative/oxidative stress. The lat-
ter was probably induced by the high prevalence in HFPEF
of metabolic comorbidities. Correction of myocardial PKG
activity could be a target for specific HFPEF treatment.
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